Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer
about
Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases.Mutation of neuraminidase cysteine residues yields temperature-sensitive influenza viruses.The future of interleukin-2: enhancing therapeutic anticancer vaccinesHyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles.Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogeneImmunogenicity of a recombinant influenza virus bearing both the CD4+ and CD8+ T cell epitopes of ovalbumin.Developing recombinant and synthetic vaccines for the treatment of melanoma.Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation.Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes.Influenza reverse genetics: dissecting immunity and pathogenesis.Local IL-21 promotes the therapeutic activity of effector T cells by decreasing regulatory T cells within the tumor microenvironment.Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency.Recombinant influenza virus vectors
P2860
Q27469314-D2A10590-AE68-4379-9FEA-EE070B6E3ABEQ33819172-E354D60E-0EF7-4639-88A8-FC73BE7F60B6Q33844221-5F8CBBBF-A193-44CC-BA59-1CE9954B06FEQ33844931-24117C97-C9B1-479B-84DA-454391020DB8Q34357182-19FB26DB-F492-45BC-98D9-80EA932845A0Q35149885-6A2EDC1E-9DF5-4124-A639-EF2AF2B33FB6Q35295462-A04B8DC3-5B28-4843-B4EA-08234218F1E5Q35946196-1E0D359C-0500-4BBA-A889-200551476D6DQ36432026-20494EA9-D7D4-4B59-853A-9E2FE6B9F3ECQ36525136-2E36F5C9-3AC5-463F-A69C-A4CE0521CF21Q38188084-62090632-301B-43A1-BC09-EC0E3990BDF1Q39503772-5D521595-7B7A-4985-BD50-60B41F745ABEQ42707023-19827AAC-764D-4BD1-A5A4-276898079EDCQ56877430-3DC9E4B2-7FE8-4ADB-9DC6-BF9CF4C488FC
P2860
Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Transfectant influenza A virus ...... eatment of experimental cancer
@en
type
label
Transfectant influenza A virus ...... eatment of experimental cancer
@en
prefLabel
Transfectant influenza A virus ...... eatment of experimental cancer
@en
P2093
P2860
P356
P1433
P1476
Transfectant influenza A virus ...... eatment of experimental cancer
@en
P2093
A García-Sastre
D R Surman
N P Restifo
S A Rosenberg
P2860
P356
10.1006/VIRO.1998.9330
P407
P50
P577
1998-09-01T00:00:00Z